newsfilter
← Latest News
PR Newswire·

Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial Commences, Participants Receive First Doses of Psilocybin

Patients receive first dose in first-ever Health Canada-approved, multi-dose psilocybin clinical trial conducted at Braxia Scientific's subsidiary CRTCE clinic Trial establishes psilocybin treatment framework for patients with TRD and opens new pathwa